The Fernández-Cruz Foundation awards the geneticist Manel Esteller



The professor of Genetics at the University of Barcelona and director of the Josep Carreras Leukemia Research Institute, Manel Esteller, has received the award from the Fernández-Cruz Foundation. The geneticist also held the memorial lesson on ‘Epigenetics in Health and Disease’. This meeting celebrated three anniversaries: the centenary of the discovery of insulin, the 40th anniversary of the first patient diagnosed with AIDS, and the 40th anniversary of the Fernández-Cruz Foundation.

The event took place at the Royal Academy of Medicine and featured an extensive scientific program divided into three important topics.

The first is to consider whether we are in a position to answer whether aging is a process derived from genetic dysregulation that can be treated and corrected.

The president of the Arturo Fernández-Cruz Foundation as moderator, Dr. Esteller as a geneticist, Dr. Blasco as an expert in the control and regulation of genes and Dr. Serrano as a researcher of the adaptation system of genes participated in the debate. cells that we call senescencents.

The pandemic that makes up obesity and diabetes is presented in the light of recent scientific evidence. The role of epigenetics in the development of obesity and its place in the development of severe forms of Covid-19 presented by professor Felipe Casanueva, professor of endocrinology at the University of Santiago de Compostela, is addressed. The successes with the new treatments that go beyond glycemic control will be discussed by Dr. Clotilde Vázquez, head of the endocrinology and nutrition service of the Jiménez Díaz Foundation. The change in the paradigm of diabetic treatment allows us to imagine that we are at the dawn of its prevention and eradication. These drugs have fully entered the therapeutic armamentarium of cardio-renal disease in non-diabetic patients. Doctors Vivencio Barrios, Cardiologist at the Ramón y Cajal Hospital and Professor Jesús Egido, professor of medicine at the Jiménez Díaz Foundation, gave an account of the scientific evidence that allows us to welcome these innovative treatments. It also opened with the presentation of Dr. Tuñón, head of the cardiology service of the Jiménez Díaz Foundation, a new effective concept to treat hypercholesterolemia with drugs that, such as vaccines, are injected monthly.

The third is the 40th anniversary of AIDS. A review of current treatments by Professor Paul Sax, director of Harvard’s division of infectious diseases, from Brigham and Women’s hospital in Boston. Presenting the evidence of the miracle achieved to control the pandemic. Professor Santiago Moreno, head of the infectious service at the Ramón y Cajal Hospital, and Professor Vicente Estrada, director of the clinical infectious unit at the Hospital Clínico, discussed this enormous feat of ensuring that the virus does not replicate. Dr. Katheleen, from the Merck company, also spoke from the United States, who provided the pharmacological novelties of long-acting retrovirals. Lastly, the program was closed with the intervention of Professor Eduardo Fernández-Cruz, head of the clinical immunology division of the Gregorio Marañón Hospital, on the novel therapeutic approach for the elimination of latent virus reservoirs. The last intervention again from the USA by Dr. Devi SenGupta, who raised whether this disease is on the verge of cure from her perspective as a virus researcher.

See them

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *